Welcome address. DIAGNOSIS. Ethics. (2 papers, 2 contributors) Methods. a. MRI (5 papers, 21 con.) b. Spectrometry (2 papers, 11 con.) c. PET (1 paper, 12 con.) d. Neurophysiology (7 papers, 30 con.) e. CSF and serum (13 papers, 53 con.) f. HLA (2 papers, 11 con.) Optic neuritis (2 papers, 12 con.) Neuropsychology (5 papers, 15 con.) SYMPTOMATIC TREATMENT. Ataxia and tremor (2 papers, 2 con.) Spasticity and pain (3 papers, 5 con.) Urinary tract (2 papers, 7 con.) NEW DEVELOPMETS. Therapies under examination. a. Steroids (6 papers, 23 con.) b. Azathioprine/Cyclosporine (2 papers, 9 con.) Experimental therapies. a. Mitoxanthrone (3 papers, 14 con.) b. Sulfosalazine (1 paper, 4 con.) c. Mab (1 paper, 7 con.) d. Irradiation (1 paper, 10 con.) Basic Research (7 papers, 42 con.) Experimental animal research (10 papers, 42 con.) MISCELLANEOUS. (3 papers, 9 con.) Index of authors.